Dynavax Technologies Corp (NASDAQ:DVAX)

Stock Price

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Friday's session. NYSE advancers led decliners by nearly 4 to ...
Read Full Story »
Test tubes

4 More Key FDA Decisions in March

24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March. Generally, companies in the pharmaceutical industry are involved in the lengthy ...
Read Full Story »
Stock Price

The 52-Week Low Club for Wednesday

March 9, 2016: Here are four stocks trading with heavy volume among 26 equities making new 52-week lows in Wednesday's session. Unisys Corp. (NYSE: UIS) fell by nearly 28% on ...
Read Full Story »
clinical trials

Dynavax Soars on Positive Late Stage Results

Dynavax Technologies Corp. (NASDAQ: DVAX) led the bulls on Thursday with positive results from a late stage clinical trial, on another consecutive down day for the broad markets. The reported ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: AK Steel, Carnival, EMC, Kinder Morgan, NVIDIA, Staples, Tyco and More

Stocks were indicated marginally lower and were still looking for direction Monday morning. Still, the S&P 500 was above 2,100 and the Dow Jones Industrial Average was above 18,100 after ...
Read Full Story »
Biotechnology word cloud

After Idenix: The Next Four Biotech Buyout Candidates

Wall Street likes nothing better than to start the week off with a bang, and pharmaceutical giant Merck & Co. Inc. (NYSE: MRK) rang the bell Monday by spending $3.85 ...
Read Full Story »
research

Top Biotech Stocks Under $5 With Huge Potential Upside

With the top stocks in the market exploding in price due to the recent rally, we wanted to scan across our research universe for some lower priced names that could ...
Read Full Story »
dollar

Short Sellers Abandon Key Nasdaq Stocks — Short Covering Galore

Short selling has always been a difficult game. One of the reasons that many investors, both institutional and retail, avoid selling stock short is the potential for loss is unlimited. ...
Read Full Story »
biotech

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Anybody that has been long the biotechnology sector for the past four years has had outstanding returns. Following four straight years of outperformance against the S&P 500, investor interest in ...
Read Full Story »
Bull and Bear figures

Closing Bell for Thursday on Wall Street: Markets Recoup from Low Open to Post Gain

U.S. equity markets opened lower this morning, but gathered steam following encouraging reports on new claims for jobless benefits (down) and retail sales (up). There was little economic data from ...
Read Full Story »
Bull and Bear figures

Closing Bell for Monday on Wall Street: Markets Open Higher, but Slip Later

U.S. equity markets opened higher this morning following some mixed economic data released in China. The country’s CPI rose less than expected, producer prices fell, fixed asset investment rose a ...
Read Full Story »
biotech

FDA Response Letter Takes over $100M from Dynavax Value

Dynavax Technologies Corp. (NASDAQ: DVAX) was a small cap stock even before today's news, but a complete response letter from U.S. Food and Drug Administration (FDA) has taken more than ...
Read Full Story »
Barnes and Noble

Today’s Market Winners and Losers

The stock market is mixed Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq up 0.17% and the S&P 500 down 0.01%. Today's winners are an online gaming firm ...
Read Full Story »

Death for Dynavax’s Lead Drug Candidate

Dynavax Technologies Corp. (NASDAQ: DVAX) is feeling the wrath of the markets after an FDA panel said that there was insufficient data to support its investigational Hepatitis B drug called ...
Read Full Story »

BioHealth Business Daily (AEZS, ANDS, ACHN, AKRX, DVAX, GENZ, IDIX, MIPI, RPRX, SNTS, WCRX)

Today's episode of the BioHealth Business Daily has many stocks moving on hepatitis news and starting with the letter "A" coincidentally.  Shares of AEterna Zentaris (NASDAQ: AEZS), Anadys Pharmaceuticals, Inc. ...
Read Full Story »